Literature DB >> 11021994

Epstein-Barr virus lacking glycoprotein gp85 cannot infect B cells and epithelial cells.

T Oda1, S Imai, S Chiba, K Takada.   

Abstract

To evaluate whether the BXLF2 gene of Epstein-Barr virus (EBV), which codes gp85 protein, is essential for infection of B cells and epithelial cells, we analyzed the infectivity of an EBV recombinant lacking gp85. The cells that were infected with the BXLF2-disrupted virus were unable to express gp85 proteins that could be detected by mouse monoclonal antibody E1D1, specific for gp85/gp25 complexes. The BXLF2-disrupted EBV had the ability to attach to, but not infect, B cells. On the other hand, the same virus failed to bind to and infect NU-GC-3, a human gastric adenocarcinoma cell line that is susceptible to EBV infection. The results indicate that the gp85 is used for infection of not only B cells but also epithelial cells and suggest that the gp85 is necessary for attaching the virus to epithelial cells. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11021994     DOI: 10.1006/viro.2000.0531

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  23 in total

1.  Soluble Epstein-Barr virus glycoproteins gH, gL, and gp42 form a 1:1:1 stable complex that acts like soluble gp42 in B-cell fusion but not in epithelial cell fusion.

Authors:  Austin N Kirschner; Jasmina Omerovic; Boris Popov; Richard Longnecker; Theodore S Jardetzky
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

2.  Cell-surface expression of a mutated Epstein-Barr virus glycoprotein B allows fusion independent of other viral proteins.

Authors:  Marisa P McShane; Richard Longnecker
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-06       Impact factor: 11.205

3.  Epstein-Barr virus shed in saliva is high in B-cell-tropic glycoprotein gp42.

Authors:  R Jiang; R S Scott; L M Hutt-Fletcher
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

Review 4.  Epstein-Barr virus entry.

Authors:  Lindsey M Hutt-Fletcher
Journal:  J Virol       Date:  2007-04-25       Impact factor: 5.103

5.  Binding-site interactions between Epstein-Barr virus fusion proteins gp42 and gH/gL reveal a peptide that inhibits both epithelial and B-cell membrane fusion.

Authors:  Austin N Kirschner; Amanda S Lowrey; Richard Longnecker; Theodore S Jardetzky
Journal:  J Virol       Date:  2007-06-20       Impact factor: 5.103

6.  Fusion of epithelial cells by Epstein-Barr virus proteins is triggered by binding of viral glycoproteins gHgL to integrins alphavbeta6 or alphavbeta8.

Authors:  Liudmila S Chesnokova; Stephen L Nishimura; Lindsey M Hutt-Fletcher
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-17       Impact factor: 11.205

7.  Glycoprotein gp110 of Epstein-Barr virus determines viral tropism and efficiency of infection.

Authors:  B Neuhierl; R Feederle; W Hammerschmidt; H J Delecluse
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-30       Impact factor: 11.205

8.  The BDLF2 protein of Epstein-Barr virus is a type II glycosylated envelope protein whose processing is dependent on coexpression with the BMRF2 protein.

Authors:  Mindy Gore; Lindsey M Hutt-Fletcher
Journal:  Virology       Date:  2008-11-07       Impact factor: 3.616

9.  Use of gHgL for attachment of Epstein-Barr virus to epithelial cells compromises infection.

Authors:  Corina M Borza; Andrew J Morgan; Susan M Turk; Lindsey M Hutt-Fletcher
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

10.  The BDLF3 gene product of Epstein-Barr virus, gp150, mediates non-productive binding to heparan sulfate on epithelial cells and only the binding domain of CD21 is required for infection.

Authors:  Liudmila S Chesnokova; Sarah M Valencia; Lindsey M Hutt-Fletcher
Journal:  Virology       Date:  2016-04-08       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.